Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.075
-0.245 (-7.38%)
At close: Sep 25, 2026, 4:00 PM EDT
3.130
+0.055 (1.79%)
After-hours: Sep 25, 2026, 7:52 PM EDT
Larimar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Basma Radwan Leerink Partners | Leerink Partners | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +322.76% | Sep 14, 2026 |
| Wedbush | Wedbush | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | +257.72% | Aug 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $25 | Buy | Maintains | $25 | +713.01% | Aug 5, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $10 | Buy | Initiates | $10 | +225.20% | Jul 2, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +62.60% | Jun 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $9 | Buy | Reiterates | $9 | +192.68% | Jun 30, 2026 |
| Citi | Citi | Buy Maintains $14 | Buy | Maintains | $14 | +355.28% | Jun 30, 2026 |